Toyama – Active surveillance is non-inferior to intravesical Bacillus Calmette-Guérin (BCG) therapy in selected patients with high-grade T1 bladder cancer. This was reported by a Japanese research group in the journal European Urology (2026; DOI: 10.1016/j.eururo.2026.01.008). High-grade T1 bladder cancers are malignant...
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Toyama – Active surveillance is non-inferior to intravesical Bacillus Calmette-Guérin (BCG) therapy in selected patients with high-grade T1 bladder cancer. This was reported by a Japanese research group in the journal European Urology (2026; DOI: 10.1016/j.eururo.2026.01.008). High-grade T1 bladder cancers are malignant...